OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular mechanisms and therapeutic implications of tetrandrine and cepharanthine in T cell acute lymphoblastic leukemia and autoimmune diseases
Wencheng Xu, Shuhe Chen, Xiaoqin Wang, et al.
Pharmacology & Therapeutics (2020) Vol. 217, pp. 107659-107659
Closed Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Natural products for combating multidrug resistance in cancer
Ting Chen, Zhicheng Xiao, Xiaoyan Liu, et al.
Pharmacological Research (2024) Vol. 202, pp. 107099-107099
Open Access | Times Cited: 28

CDK inhibitor Palbociclib targets STING to alleviate autoinflammation
Jiani Gao, Mengge Zheng, Xiangyang Wu, et al.
EMBO Reports (2022) Vol. 23, Iss. 6
Open Access | Times Cited: 43

Pharmacological Activity of Cepharanthine
Ke Liu, Bixia Hong, Shuqi Wang, et al.
Molecules (2023) Vol. 28, Iss. 13, pp. 5019-5019
Open Access | Times Cited: 22

Tetrandrine activates STING/TBK1/IRF3 pathway to potentiate anti-PD-1 immunotherapy efficacy in non-small cell lung cancer
Yan Zhi Tan, Qiancheng Zhu, Meilin Yang, et al.
Pharmacological Research (2024) Vol. 207, pp. 107314-107314
Open Access | Times Cited: 9

Structural bases of inhibitory mechanism of CaV1.2 channel inhibitors
Yiqing Wei, Zhuoya Yu, Lili Wang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8

Cepharanthine, a regulator of keap1-Nrf2, inhibits gastric cancer growth through oxidative stress and energy metabolism pathway
Yangyang Lu, Chunyang Zhu, Yixin Ding, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 16

Pharmacological Effects and Clinical Prospects of Cepharanthine
Di Liang, Qi Li, Lina Du, et al.
Molecules (2022) Vol. 27, Iss. 24, pp. 8933-8933
Open Access | Times Cited: 22

Mechanism of ferroptosis in breast cancer and research progress of natural compounds regulating ferroptosis
Anqi Ge, Qi He, Zhao Da, et al.
Journal of Cellular and Molecular Medicine (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 12

Tetrandrine Represses Inflammation and Attenuates Osteoarthritis by Selective Inhibition of COX-2
Ping Gao, Zhi-wei Rao, Min Li, et al.
Current Medical Science (2023) Vol. 43, Iss. 3, pp. 505-513
Closed Access | Times Cited: 11

A tri-compound formula comprising ginsenoside Rg1, tetrandrine and icariin alleviates atopic dermatitis symptoms in a mouse model
Ying Wu, Xiaoqi Wang, Jia‐Ying Wu, et al.
Phytomedicine (2025), pp. 156737-156737
Closed Access

Tetrandrine (TET) inhibits African swine fever virus entry into cells by blocking the PI3K/Akt pathway
Bingxu Qian, Yongxin Hu, Cong Liu, et al.
Virus Research (2023) Vol. 339, pp. 199258-199258
Open Access | Times Cited: 10

Cepharanthine Triggers Ferroptosis Through Inhibition of NRF2 For Robust ER Stress Against Lung Cancer
Xiaofeng Bai, Jun Hu, Meifang Wang, et al.
European Journal of Pharmacology (2024) Vol. 979, pp. 176839-176839
Closed Access | Times Cited: 3

Pulmonary administration of tetrandrine loaded Zinc-Alginate nanogels attenuates pulmonary fibrosis in rats
Na Kou, Yibing Chen, Xianwen Li, et al.
International Journal of Pharmaceutics (2023) Vol. 649, pp. 123625-123625
Closed Access | Times Cited: 7

The biology and total syntheses of bisbenzylisoquinoline alkaloids
Viviene K. Nguyen, Kevin G. M. Kou
Organic & Biomolecular Chemistry (2021) Vol. 19, Iss. 35, pp. 7535-7543
Open Access | Times Cited: 15

Cepharanthine synergizes with photodynamic therapy for boosting ROS-driven DNA damage and suppressing MTH1 as a potential anti-cancer strategy
Ziyi Yang, Liu‐Gen Li, Yi-Lian Xiong, et al.
Photodiagnosis and Photodynamic Therapy (2023) Vol. 45, pp. 103917-103917
Open Access | Times Cited: 5

Tetrandrine inhibits RANKL-induced osteoclastogenesis by promoting the degradation of TRAIL
Jiarui Li, Xiang Li, Shengji Zhou, et al.
Molecular Medicine (2022) Vol. 28, Iss. 1
Open Access | Times Cited: 8

Antiviral effects and tissue exposure of tetrandrine against SARS‐CoV‐2 infection and COVID‐19
Jia Liu, Furun Wang, Xi Wang, et al.
MedComm (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 4

Translating molecular insights into clinical success: alkaloid-based therapies for leukemia
Pouya Goleij, Mohammad Amin Khazeei Tabari, Aryan Rezaee, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access | Times Cited: 1

Assessing the potential of repurposing ion channel inhibitors to treat emerging viral diseases and the role of this host factor in virus replication
Tristan Russell, Disha Gangotia, Gerald Barry
Biomedicine & Pharmacotherapy (2022) Vol. 156, pp. 113850-113850
Open Access | Times Cited: 5

Efficacy and safety of tetrandrine in treatment of rheumatoid arthritis: a meta-analysis
Juan Xu, Jichen Li, Ye Yan, et al.
Journal of Zhejiang University (Medical Sciences) (2024) Vol. 53, Iss. 4, pp. 519-526
Open Access

Page 1 - Next Page

Scroll to top